Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
1.560
-0.050 (-3.11%)
At close: Jan 17, 2025, 4:00 PM
1.500
-0.060 (-3.84%)
After-hours: Jan 17, 2025, 7:54 PM EST
Impact BioMedical Employees
Impact BioMedical had 1 employees as of December 31, 2023. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
$1,165,000
Market Cap
17.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IBO News
- 3 months ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 3 months ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 4 months ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 4 months ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire
- 4 months ago - Impact BioMedical Inc. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Impact BioMedical IPO Registration Document (S-1) - SEC